human coronavirus

人类冠状病毒
  • 文章类型: Journal Article
    冠状病毒可以引起各种疾病,从轻度症状到最近的严重COVID-19。冠状病毒RNA基因组由于其RNA性质而经常发生突变,导致许多致病和耐药变异。因此,应该准备许多药物来应对各种冠状病毒变体。在这份报告中,我们证明连翘果实乙醇提取物(FVFE)可有效减少冠状病毒的复制。我们试图鉴定活性化合物,发现来自FVFE的肌动蛋白可有效减少人类冠状病毒的复制。牛皮苷元处理可降低冠状病毒蛋白表达和冠状病毒诱导的细胞毒性。这些结果共同表明,牛熊果苷元是一种有效的天然化合物,可防止冠状病毒复制。
    Coronavirus can cause various diseases, from mild symptoms to the recent severe COVID-19. The coronavirus RNA genome is frequently mutated due to its RNA nature, resulting in many pathogenic and drug-resistant variants. Therefore, many medicines should be prepared to respond to the various coronavirus variants. In this report, we demonstrated that Forsythia viridissima fruit ethanol extract (FVFE) effectively reduces coronavirus replication. We attempted to identify the active compounds and found that actigenin from FVFE effectively reduces human coronavirus replication. Arctigenin treatment can reduce coronavirus protein expression and coronavirus-induced cytotoxicity. These results collectively suggest that arctigenin is a potent natural compound that prevents coronavirus replication.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    冠状病毒病2019大流行说明了了解人类致病病毒在环境中的行为和控制的重要性。通过水暴露(饮用,洗澡,和娱乐)是已知的病毒传播给人类的途径,但是文献中对许多病毒的持久性的研究相对缺乏,尤其是冠状病毒,在水中及其对氯消毒的敏感性。为了填补知识空白,我们评估了人类冠状病毒OC43(HCoV-OC43)及其替代品的持久性和游离氯消毒,鼠肝炎病毒(MHV)和猪传染性胃肠炎病毒(TGEV),在饮用水和实验室缓冲液中使用细胞培养方法。人类冠状病毒及其替代物在水中的衰减速率常数各不相同,取决于病毒和水基质。在不添加消毒剂的饮用水中,MHV显示出最大的衰减速率常数(估计值±标准误差,2.25±0.09天-1),然后是HCoV-OC43(0.99±0.12天-1)和TGEV(0.65±0.06天-1),在不添加消毒剂的磷酸盐缓冲液中,HCoV-OC43(0.51±0.10天-1)的衰减速率常数大于MHV(0.28±0.03天-1)和TGEV(0.24±0.02天-1)。经过游离氯消毒,冠状病毒的灭化率与游离氯浓度无关,不受基质水的影响,尽管它们在病毒之间仍然有所不同。TGEV对游离氯消毒的敏感性最高,失活速率常数为113.50±7.50mg-1min-1L,其次是MHV(81.33±4.90mg-1min-1L)和HCoV-OC43(59.42±4.41mg-1min-1L)。
    目的:这项研究解决了包膜病毒持久性和水中消毒的重要知识空白。结果对于制定基于证据的水政策具有直接的实际应用,特别是在病原病毒控制的消毒策略的发展。
    The coronavirus disease 2019 pandemic illustrates the importance of understanding the behavior and control of human pathogenic viruses in the environment. Exposure via water (drinking, bathing, and recreation) is a known route of transmission of viruses to humans, but the literature is relatively void of studies on the persistence of many viruses, especially coronaviruses, in water and their susceptibility to chlorine disinfection. To fill that knowledge gap, we evaluated the persistence and free chlorine disinfection of human coronavirus OC43 (HCoV-OC43) and its surrogates, murine hepatitis virus (MHV) and porcine transmissible gastroenteritis virus (TGEV), in drinking water and laboratory buffer using cell culture methods. The decay rate constants of human coronavirus and its surrogates in water varied, depending on virus and water matrix. In drinking water without disinfectant addition, MHV showed the largest decay rate constant (estimate ± standard error, 2.25 ± 0.09 day-1) followed by HCoV-OC43 (0.99 ± 0.12 day-1) and TGEV (0.65 ± 0.06 day-1), while in phosphate buffer without disinfectant addition, HCoV-OC43 (0.51 ± 0.10 day-1) had a larger decay rate constant than MHV (0.28 ± 0.03 day-1) and TGEV (0.24 ± 0.02 day-1). Upon free chlorine disinfection, the inactivation rates of coronaviruses were independent of free chlorine concentration and were not affected by water matrix, though they still varied between viruses. TGEV showed the highest susceptibility to free chlorine disinfection with the inactivation rate constant of 113.50 ± 7.50 mg-1 min-1 L, followed by MHV (81.33 ± 4.90 mg-1 min-1 L) and HCoV-OC43 (59.42 ± 4.41 mg-1 min-1 L).
    OBJECTIVE: This study addresses an important knowledge gap on enveloped virus persistence and disinfection in water. Results have immediate practical applications for shaping evidence-based water policies, particularly in the development of disinfection strategies for pathogenic virus control.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    新兴的生物污染物(空气传播病毒)利用和操纵宿主(人类)代谢产生新的病毒颗粒,逃避宿主的免疫防御并导致感染。非热等离子体,在大气压和环境温度下运行,正在探索病毒灭活,产生与病毒蛋白相互作用和变性的RONS。然而,影响病毒存活的各种因素影响非热等离子体的功效。葡萄糖类似物2-DG,这项研究中使用的代谢调节剂,破坏了病毒所依赖的糖酵解途径,为复制创造不利的环境。这里,空气中的HCoV-229E生物污染物用等离子体处理灭活,并分析了RONS的存在。随后将代谢改变的肺细胞暴露于经处理的空气传播病毒。细胞病变效应,刺突蛋白,通过流式细胞术和共聚焦显微镜评估细胞死亡,使用PCR评估CPRR介导的抗病毒基因表达。气体等离子体处理的病毒导致未改变的肺细胞中病毒增殖减少,尽管很少有病毒颗粒在暴露中幸存下来,如生物学评估(细胞病变效应和活/死染色)所证实。与对照组相比,气体等离子体处理的病毒和改变的肺细胞的组合方法显示出病毒的急剧减少。通过共聚焦显微镜和流式细胞术建立。此外,当暴露于气体等离子体处理的病毒时,改变的肺细胞增强负责先天免疫的基因转录,从而阻碍空气传播病毒的传播。这项研究证明了表面空气气体等离子体和代谢改变方法在增强针对抗病毒先天免疫的基因和解决新兴生物污染物(空气传播病毒)爆发方面的重要性。
    Emerging bio-contaminants (airborne viruses) exploits and manipulate host (human) metabolism to produce new viral particles, evading the host\'s immune defences and leading to infections. Non-thermal plasma, operating at atmospheric pressure and ambient temperature, is explored for virus inactivation, generating RONS that interact and denatures viral proteins. However, various factors affecting virus survival influence the efficacy of non-thermal plasma. Glucose analogue 2-DG, a metabolic modifier used in this study, disrupts the glycolysis pathway viruses rely on, creating an unfavourable environment for replication. Here, airborne HCoV-229E bio-contaminant was treated with plasma for inactivation, and the presence of RONS was analysed. Metabolically altered lung cells were subsequently exposed to the treated airborne viruses. Cytopathic effect, spike protein, and cell death were evaluated via flow cytometry and confocal microscopy, and CPRRs mediated antiviral gene expression was evaluated using PCR. Gas plasma-treated viruses led to reduced virus proliferation in unaltered lung cells, although few virus particles survived the exposure, as confirmed by biological assessment (cytopathic effects and live/dead staining). A combination approach of gas plasma-treated viruses and altered lung cells displayed drastic virus reduction compared to the control group, established through confocal microscopy and flow cytometry. Furthermore, altered lung cell enhances gene transcription responsible for innate immunity when exposed to the gas plasma-treated virus, thereby impeding airborne virus propagation. This study demonstrates the significance of a surface air gas plasma and metabolic alteration approach in enhancing genes targeted towards antiviral innate immunity and tackling outbreaks of emerging bio-contaminants of concerns (airborne viruses).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    我们报告了圣保罗住院患者和医护人员中的人类冠状病毒OC43感染暴发,巴西,SARS-CoV-2病例消失后发生。5例(29.4%)患者感染与医护人员相关。包括呼吸道病毒小组在内的常规监测可以改善医疗保健专业人员和患者的冠状病毒检测。
    We report a human coronavirus OC43 infection outbreak in hospitalized patients and healthcare workers in São Paulo, Brazil, occurring after SARS-CoV-2 cases disappeared. Infection was associated with healthcare workers in 5 (29.4%) patients. Routine surveillance including a respiratory virus panel can improve coronavirus detection in both healthcare professionals and patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目标:在季节性和病毒爆发期间,实施抗病毒塑料可以作为限制病毒从污染表面传播的积极策略,补充现有的卫生习惯。在这项研究中,我们展示了松香功能化塑料表面的功效,在接触时间的15分钟内杀死人类冠状病毒的病毒感染性,不管湿度水平。相比之下,非功能化的塑料表面保持病毒的感染力长达48小时。表面上的瞬时附着或浸出的活性成分不会引起病毒的重大结构变化或阻止受体结合;相反,它们有效地在内体阶段阻断病毒感染。
    Viruses may persist on solid surfaces for long periods, which may contribute to indirect transmission. Thus, it is imperative to develop functionalized surfaces that will lower the infectious viral load in everyday life. Here, we have tested a plastic surface functionalized with tall oil rosin against the seasonal human coronavirus OC43 as well as severe acute respiratory syndrome coronavirus 2. All tested non-functionalized plastic surfaces showed virus persistence up to 48 h. In contrast, the functionalized plastic showed good antiviral action already within 15 min of contact and excellent efficacy after 30 min over 90% humidity. Excellent antiviral effects were also observed at lower humidities of 20% and 40%. Despite the hydrophilic nature of the functionalized plastic, viruses did not adhere strongly to it. According to helium ion microscopy, viruses appeared flatter on the rosin-functionalized surface, but after flushing away from the rosin-functionalized surface, they showed no apparent structural changes when imaged by transmission electron microscopy of cryogenic or negatively stained specimens or by atomic force microscopy. Flushed viruses were able to bind to their host cell surface and enter endosomes, suggesting that the fusion with the endosomal membrane was halted. The eluted rosin from the functionalized surface demonstrated its ability to inactivate viruses, indicating that the antiviral efficacy relied on the active leaching of the antiviral substances, which acted on the viruses coming into contact. The rosin-functionalized plastic thus serves as a promising candidate as an antiviral surface for enveloped viruses.IMPORTANCEDuring seasonal and viral outbreaks, the implementation of antiviral plastics can serve as a proactive strategy to limit the spread of viruses from contaminated surfaces, complementing existing hygiene practices. In this study, we show the efficacy of a rosin-functionalized plastic surface that kills the viral infectivity of human coronaviruses within 15 min of contact time, irrespective of the humidity levels. In contrast, non-functionalized plastic surfaces retain viral infectivity for an extended period of up to 48 h. The transient attachment on the surface or the leached active components do not cause major structural changes in the virus or prevent receptor binding; instead, they effectively block viral infection at the endosomal stage.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    T细胞免疫在2019年冠状病毒传染病(COVID-19)的临床结果中起着核心作用,T细胞聚焦疫苗或细胞免疫疗法可能会为一些免疫功能低下的患者提供增强的保护。预先存在的识别SARS-CoV-2抗原的T细胞记忆,可以在COVID-19感染或疫苗接种之前,可能已经发展成为地方性非SARS人类冠状病毒(hCoVs)OC43,HKU1,229E,NL63,“普通感冒”病原体。反过来,SARS-CoV-2引发的T细胞可以识别新出现的变体或其他hCoV病毒并调节随后的hCoV感染的过程。hCoV和SARS-CoV-2之间的交叉免疫尚未得到很好的表征。这里,我们系统地研究了T细胞对免疫显性SARS-CoV-2峰值的反应,在接种疫苗中,来自α-和β-hCoV的核衣壳蛋白和膜蛋白以及相应的抗原,疗养者,和未暴露的主题。在COVID-19幸存者中出现了针对所有测试的SARS-CoV-2抗原的广泛T细胞免疫。在康复期和接种疫苗的个体中,SARS-CoV-2尖峰特异性T细胞可靠地识别大多数SARS-CoV-2变体,然而,与omicron变异体的交叉反应性降低了约47%.对尖峰的回应,来自地方性hCoV的核衣壳和膜抗原在COVID-19幸存者中比未暴露受试者明显更广泛,并且在α-和β-hCoV之间表现出交叉反应性。在一些,非SARShCoV特异性T细胞与SARS-CoV-2抗原表现出突出的非相互交叉反应性,而COVID-19后出现了明显的抗SARS-CoV-2免疫库,对非SARShCoV的交叉识别相对有限。基于这种交叉反应模式,我们建立了用于过继性免疫治疗的通用抗hCoVT细胞体外扩增策略.总的来说,这些结果对未来针对SARS和非SARS-CoV的通用疫苗和基于细胞的免疫疗法的设计具有重要意义.
    T cell immunity plays a central role in clinical outcomes of Coronavirus Infectious Disease 2019 (COVID-19) and T cell-focused vaccination or cellular immunotherapy might provide enhanced protection for some immunocompromised patients. Pre-existing T cell memory recognizing SARS-CoV-2 antigens antedating COVID-19 infection or vaccination, may have developed as an imprint of prior infections with endemic non-SARS human coronaviruses (hCoVs) OC43, HKU1, 229E, NL63, pathogens of \"common cold\". In turn, SARS-CoV-2-primed T cells may recognize emerging variants or other hCoV viruses and modulate the course of subsequent hCoV infections. Cross-immunity between hCoVs and SARS-CoV-2 has not been well characterized. Here, we systematically investigated T cell responses against the immunodominant SARS-CoV-2 spike, nucleocapsid and membrane proteins and corresponding antigens from α- and β-hCoVs among vaccinated, convalescent, and unexposed subjects. Broad T cell immunity against all tested SARS-CoV-2 antigens emerged in COVID-19 survivors. In convalescent and in vaccinated individuals, SARS-CoV-2 spike-specific T cells reliably recognized most SARS-CoV-2 variants, however cross-reactivity against the omicron variant was reduced by approximately 47%. Responses against spike, nucleocapsid and membrane antigens from endemic hCoVs were significantly more extensive in COVID-19 survivors than in unexposed subjects and displayed cross-reactivity between α- and β-hCoVs. In some, non-SARS hCoV-specific T cells demonstrated a prominent non-reciprocal cross-reactivity with SARS-CoV-2 antigens, whereas a distinct anti-SARS-CoV-2 immunological repertoire emerged post-COVID-19, with relatively limited cross-recognition of non-SARS hCoVs. Based on this cross-reactivity pattern, we established a strategy for in-vitro expansion of universal anti-hCoV T cells for adoptive immunotherapy. Overall, these results have implications for the future design of universal vaccines and cell-based immune therapies against SARS- and non-SARS-CoVs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    新出现和重新出现的病毒定期在世界各地引起爆发和流行,这最终导致了诸如COVID-19大流行之类的全球事件。因此,迫切需要新的抗病毒药物是显而易见的。在一个多世纪的抗病毒开发过程中,核苷类似物已被证明是对抗多样化DNA和RNA病毒的有前途的试剂。这里,我们介绍了基于羟基苯并[4,5]咪唑并[1,2-c]嘧啶-1(2H)-酮支架的核苷类似物及其去糖基化衍生物的抗病毒活性的合成和评估。针对一组结构上和系统发育上不同的RNA和DNA病毒评估了抗病毒活性。前导化合物对冠状病毒科的代表显示出微摩尔活性,包括SARS-CoV-2,以及针对亚微摩尔范围内的呼吸道合胞病毒,对宿主细胞无明显毒性。令人惊讶的是,前导化合物的芳族羟基的甲基化导致针对水痘带状疱疹病毒的微摩尔活性,而对细胞活力没有任何显着影响。前导化合物被证明是SARS-CoV-2RNA依赖性RNA聚合酶的弱抑制剂。它还抑制了对SARS-CoV-2复制重要的生物缩合物的形成。活性化合物可以被认为是进一步结构优化以及机理和临床前研究的良好起点。
    Emerging and re-emerging viruses periodically cause outbreaks and epidemics around the world, which ultimately lead to global events such as the COVID-19 pandemic. Thus, the urgent need for new antiviral drugs is obvious. Over more than a century of antiviral development, nucleoside analogs have proven to be promising agents against diversified DNA and RNA viruses. Here, we present the synthesis and evaluation of the antiviral activity of nucleoside analogs and their deglycosylated derivatives based on a hydroxybenzo[4,5]imidazo[1,2-c]pyrimidin-1(2H)-one scaffold. The antiviral activity was evaluated against a panel of structurally and phylogenetically diverse RNA and DNA viruses. The leader compound showed micromolar activity against representatives of the family Coronaviridae, including SARS-CoV-2, as well as against respiratory syncytial virus in a submicromolar range without noticeable toxicity for the host cells. Surprisingly, methylation of the aromatic hydroxyl group of the leader compound resulted in micromolar activity against the varicella-zoster virus without any significant impact on cell viability. The leader compound was shown to be a weak inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase. It also inhibited biocondensate formation important for SARS-CoV-2 replication. The active compounds may be considered as a good starting point for further structure optimization and mechanistic and preclinical studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    伴随着由严重急性呼吸道综合症冠状病毒2(SARS-CoV-2)引起的COVID-19的长期大流行,出现了令人关注的病毒变体(VOC)的困境,特别是Omicron及其亚变体,能够巧妙地逃避免疫监视和当前疫苗和抗体药物的其他保护作用。我们以前鉴定了一种基于肽的泛CoV融合抑制剂,称为EK1,能够结合病毒刺突(S)蛋白S2亚基中的HR1区域。这有效地阻止了六螺旋束(6-HB)融合核的形成,因此,显示了对所有人类冠状病毒(HCoV)的功效。EK1目前正在进行3期临床试验。然而,肽药物通常缺乏口服可用性。因此,我们在此对生物活性分子文库进行了基于结构的虚拟筛选,并鉴定了9种候选化合物.一个是Navitoclax,通过抑制Bcl-2的口服活性抗癌药物。像EK1肽,它可以结合HR1并阻断6-HB的形成,有效抑制所有测试的SARS-CoV-2变体的融合和感染,以及SARS-CoV和MERS-CoV,IC50值范围为0.5至3.7μM。这些发现表明,Navitoclax是一种有前途的可再利用的候选药物,可作为一种安全和口服的广谱抗病毒药物来对抗当前的SARS-CoV-2及其变体,以及其他HCoV。
    Along with the long pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has come the dilemma of emerging viral variants of concern (VOC), particularly Omicron and its subvariants, able to deftly escape immune surveillance and the otherwise protective effect of current vaccines and antibody drugs. We previously identified a peptide-based pan-CoV fusion inhibitor, termed as EK1, able to bind the HR1 region in viral spike (S) protein S2 subunit. This effectively blocked formation of the six-helix bundle (6-HB) fusion core and, thus, showed efficacy against all human coronaviruses (HCoVs). EK1 is now in phase 3 clinical trials. However, the peptide drug generally lacks oral availability. Therefore, we herein performed a structure-based virtual screening of the libraries of biologically active molecules and identified nine candidate compounds. One is Navitoclax, an orally active anticancer drug by inhibition of Bcl-2. Like EK1 peptide, it could bind HR1 and block 6-HB formation, efficiently inhibiting fusion and infection of all SARS-CoV-2 variants tested, as well as SARS-CoV and MERS-CoV, with IC50 values ranging from 0.5 to 3.7 μM. These findings suggest that Navitoclax is a promising repurposed drug candidate for development as a safe and orally available broad-spectrum antiviral drug to combat the current SARS-CoV-2 and its variants, as well as other HCoVs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    缺乏合适的体外培养模型阻碍了对野生型(WT)人冠状病毒的研究。虽然3D组织或器官培养有助于实现这一目的,这样的模型具有挑战性,耗时,价格昂贵,需要广泛的细胞培养适应和定向进化。因此,在大多数情况下,高通量应用是无法实现的。在这里,我们通过转导CD13和跨膜丝氨酸蛋白酶2(TMPRSS2)开发了一种强大的A549细胞系,允许人类冠状病毒229E(HCoV-229E)临床分离株,此后称为A549++细胞。这种修改允许生产性感染,更详细的分析表明,该病毒可能使用TMPRSS2依赖性途径,但仍可利用组织蛋白酶介导的内吞作用绕过该途径.总的来说,我们的数据显示,A549++细胞允许HCoV-229E临床分离株,并适用于HCoV-229E感染的进一步研究。此外,这条线构成了对冠状病毒科多个成员进行研究的统一平台。
    The lack of suitable in vitro culture model has hampered research on wild-type (WT) human coronaviruses. While 3D tissue or organ cultures have been instrumental for this purpose, such models are challenging, time-consuming, expensive and require extensive cell culture adaptation and directed evolution. Consequently, high-throughput applications are beyond reach in most cases. Here we developed a robust A549 cell line permissive to a human coronavirus 229E (HCoV-229E) clinical isolate by transducing CD13 and transmembrane serine protease 2 (TMPRSS2), henceforth referred to as A549++ cells. This modification allowed for productive infection, and a more detailed analysis showed that the virus might use the TMPRSS2-dependent pathway but can still bypass this pathway using cathepsin-mediated endocytosis. Overall, our data showed that A549++ cells are permissive to HCoV-229E clinical isolate, and applicable for further studies on HCoV-229E infectiology. Moreover, this line constitutes a uniform platform for studies on multiple members of the Coronaviridae family.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    自2020年以来,严重急性呼吸道综合症冠状病毒-2(SARS-CoV-2)一直是引发全球大流行的原因。病毒通过污染的空气颗粒传播,fomite,和表面污染的多孔(即,paper,木头,和面罩)和无孔(即,塑料,不锈钢,和玻璃)材料。病毒在材料上的持久性取决于孔隙度,吸附,蒸发,等电点,和环境条件,如温度,pH值,和相对湿度。消毒技术对于防止动画和无生命表面上的病毒污染至关重要。目前,很少有有效的方法来预防SARS-CoV-2和其他冠状病毒而没有任何副作用。在感染发生之前,必须采取措施防止冠状病毒在多孔和无孔无生命材料表面的持续存在。这篇综述的重点是表面材料(无生命)中冠状病毒的持久性和控制措施。病毒通过化学和物理方法灭活;化学方法特别包括酒精,氯,和过氧化物,而温度,pH值,湿度,湿度紫外线照射(UV),伽马辐射,X光片,臭氧,和非热,等离子体产生的活性氧和氮(RONS)是物理方法。
    Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been responsible for the initiation of the global pandemic since 2020. The virus spreads through contaminated air particles, fomite, and surface-contaminated porous (i.e., paper, wood, and masks) and non-porous (i.e., plastic, stainless steel, and glass) materials. The persistence of viruses on materials depends on porosity, adsorption, evaporation, isoelectric point, and environmental conditions, such as temperature, pH, and relative humidity. Disinfection techniques are crucial for preventing viral contamination on animated and inanimate surfaces. Currently, there are few effective methodologies for preventing SARS-CoV-2 and other coronaviruses without any side effects. Before infection can occur, measures must be taken to prevent the persistence of the coronavirus on the surfaces of both porous and non-porous inanimate materials. This review focuses on coronavirus persistence in surface materials (inanimate) and control measures. Viruses are inactivated through chemical and physical methods; the chemical methods particularly include alcohol, chlorine, and peroxide, whereas temperature, pH, humidity, ultraviolet irradiation (UV), gamma radiation, X-rays, ozone, and non-thermal, plasma-generated reactive oxygen and nitrogen species (RONS) are physical methods.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号